Thiodigalactoside

Overview

Thiodigalactoside (TDG) is an orally active and potent galectin (GAL) inhibitor with K d values of 24 μM, 49 μM for GAL1 and GAL3, respectively. Thiodigalactoside, a non-metabolizable disaccharide, has anti-inflammatory and anti-cancer activity. Thiodigalactoside dramatically reduces body weight gain in diet-induced obese rats.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Signaling Pathways > Galectin

Product Information

• Catalog No.: HY-130208
• CAS No.: 51555-87-4
• Molecular Formula: C12H22O10S
• Molecular Weight: 358.36
• Purity: 99.92%
• Storage: -20°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: 100 mg/mL (279.05 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source